Health Care: Drugs

Hemispherx Biopharma Inc (HEB: AMEX)

$0.1222 0.0021 | 1.75%
05/27/16 - 03:56 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 133.00K 197.00K 150.00K 213.00K
Cost of Sales 408.00K 109.00K 367.00K 1.31M
Gross Operating Profit -275.00K 88.00K -217.00K -1.09M
Selling, General, and Administrative Expenses 7.15M 9.06M 7.72M 9.06M
Research & Development 8.04M 8.99M 8.36M 9.51M
Operating Income before D & A (EBITDA) -15.46M -17.96M -16.30M -19.66M
Depreciation & Amortization 1.19M 1.14M 867.00K 683.00K
Interest Income 364.00K 665.00K 791.00K 1.60M
Other Income - Net 1.06M 995.00K 167.00K 1.41M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -15.23M -17.44M -16.21M -17.33M
Interest Expense 3.00K 11.00K 16.00K 24.00K
Pre-Tax Income -15.23M -17.45M -16.23M -17.35M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -15.23M -17.45M -16.23M -17.35M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -15.23M -17.45M -16.23M -17.35M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -15.23M -17.45M -16.23M -17.35M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-15.23M -17.45M -16.23M -17.35M
Preferred Dividends
Net Income Available To Common -15.23M -17.45M -16.23M -17.35M
Basic EPS from Continuing Ops. -0.06 -0.09 -0.10 -0.12
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.06 -0.09 -0.10 -0.12
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.06 -0.09 -0.10 -0.12
Basic Normalized Net Income/Share -0.06 -0.09 -0.10 -0.12
EPS fr Continuing Ops. -0.06 -0.09 -0.10 -0.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.06 -0.09 -0.10 -0.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.06 -0.09 -0.10 -0.12
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.06 -0.09 -0.10 -0.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with HEB

Latest HEB Headlines from TheStreet

More Financial News for HEB

Press Releases for HEB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter